Since surfactants have been shown to be important in restricting pneumococcal pneumonia (23), it is likely that the compounded effects of both surfactant and IL-22 depletion by PIV are aiding in pneumococcal ability to overcome mucosal barriers to invasive disease. The gene discussed is IL22; the disease is pneumococcal pneumonia.